254 related articles for article (PubMed ID: 16564918)
1. Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.
Krauth MT; Agis H; Aichberger KJ; Simonitsch-Klupp I; Müllauer L; Mayerhofer M; Böhm A; Horny HP; Valent P
Hum Pathol; 2006 Apr; 37(4):439-47. PubMed ID: 16564918
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.
Samorapoompichit P; Schernthaner GH; Worda C; Wimazal F; Krauth MT; Sperr WR; Valent P
Histopathology; 2006 Feb; 48(3):247-57. PubMed ID: 16430471
[TBL] [Abstract][Full Text] [Related]
3. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).
Jordan JH; Walchshofer S; Jurecka W; Mosberger I; Sperr WR; Wolff K; Chott A; Bühring HJ; Lechner K; Horny HP; Valent P
Hum Pathol; 2001 May; 32(5):545-52. PubMed ID: 11381374
[TBL] [Abstract][Full Text] [Related]
5. Inductions of histidine decarboxylase in mouse tissues following systemic antigen challenge: contributions made by mast cells, non-mast cells and IL-1.
Deng X; Wu X; Yu Z; Arai I; Sasano T; Sugawara S; Endo Y
Int Arch Allergy Immunol; 2007; 144(1):69-78. PubMed ID: 17505141
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.
Baumgartner C; Sonneck K; Krauth MT; Kneidinger M; Födinger M; Hauswirth AW; Müllauer L; Valent P
Eur J Clin Invest; 2008 May; 38(5):326-35. PubMed ID: 18363719
[TBL] [Abstract][Full Text] [Related]
7. Real-time RT-PCR analysis of human histidine decarboxylase, a new marker for several types of leukemia and cancer.
Melgarejo E; Medina MA; Paz JC; Sánchez-Jiménez F; Urdiales JL
Oncol Rep; 2006 Jan; 15(1):193-7. PubMed ID: 16328055
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells.
Valent P; Cerny-Reiterer S; Herrmann H; Mirkina I; George TI; Sotlar K; Sperr WR; Horny HP
Best Pract Res Clin Haematol; 2010 Sep; 23(3):369-78. PubMed ID: 21112036
[TBL] [Abstract][Full Text] [Related]
9. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
10. Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis.
Anlauf M; Schäfer MK; Schwark T; von Wurmb-Schwark N; Brand V; Sipos B; Horny HP; Parwaresch R; Hartschuh W; Eiden LE; Klöppel G; Weihe E
J Histochem Cytochem; 2006 Feb; 54(2):201-13. PubMed ID: 16116033
[TBL] [Abstract][Full Text] [Related]
11. Induction of L-histidine decarboxylase in a human mast cell line, HMC-1.
Maeda K; Taniguchi H; Ohno I; Ohtsu H; Yamauchi K; Sakurai E; Tanno Y; Butterfield JH; Watanabe T; Shirato K
Exp Hematol; 1998 Apr; 26(4):325-31. PubMed ID: 9546316
[TBL] [Abstract][Full Text] [Related]
12. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
[TBL] [Abstract][Full Text] [Related]
13. Expression of non-mast cell histidine decarboxylase in tumor-associated microvessels in human esophageal squamous cell carcinomas.
Li Z; Liu J; Tang F; Liu Y; Waldum HL; Cui G
APMIS; 2008 Dec; 116(12):1034-42. PubMed ID: 19133005
[TBL] [Abstract][Full Text] [Related]
14. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M
Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
[TBL] [Abstract][Full Text] [Related]
15. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
Siegert SI; Diebold J; Ludolph-Hauser D; Löhrs U
Am J Clin Pathol; 2004 Oct; 122(4):560-5. PubMed ID: 15487454
[TBL] [Abstract][Full Text] [Related]
16. Biology, classification and treatment of human mastocytosis.
Valent P
Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
[TBL] [Abstract][Full Text] [Related]
17. Multiple sites of L-histidine decarboxylase expression in mouse suggest novel developmental functions for histamine.
Karlstedt K; Nissinen M; Michelsen KA; Panula P
Dev Dyn; 2001 May; 221(1):81-91. PubMed ID: 11357196
[TBL] [Abstract][Full Text] [Related]
18. Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors: immunohistochemical study and gene expression analysis.
Uccella S; Cerutti R; Vigetti D; Furlan D; Oldrini R; Carnevali I; Pelosi G; La Rosa S; Passi A; Capella C
J Histochem Cytochem; 2006 Aug; 54(8):863-75. PubMed ID: 16517981
[TBL] [Abstract][Full Text] [Related]
19. Detection of histidine decarboxylase in rat aorta and cultured rat aortic smooth muscle cells.
Tippens AS; Davis SV; Hayes JR; Bryda EC; Green TL; Gruetter CA
Inflamm Res; 2004 Aug; 53(8):390-5. PubMed ID: 15316670
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.
Olafsson JH
Acta Derm Venereol Suppl (Stockh); 1985; 115():1-43. PubMed ID: 3901645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
